Earth Science Tech AI Stock Analysis
Want to see ETST full AI Analyst Report?
Earth Science Tech (ETST) AI Stock Analysis
Earth Science Tech
(Other OTC:ETST)
The overall score of 67 reflects a company with a strong fundamental turnaround and exciting strategic moves, but whose stock is under significant technical pressure. The pristine balance sheet and accretive acquisitions are major strengths, while the recent revenue decline and weak price trend are the primary risks. The very low P/E ratio offers a compelling valuation, but the stock's downtrend suggests the market is not yet convinced about the sustainability of the turnaround.
Earth Science Tech (ETST) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $26.49M
- Dividend Yield
- ―
- Average Volume (3M)
- 73.05K
- Price to Earnings (P/E)
- 7.2
- Beta (1Y)
- 2.35
- Revenue Growth
- 1.09%
- EPS Growth
- 35.79%
- Country
- US
- Employees
- 77
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Earth Science Tech Business Overview & Revenue Model
Company Description
Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements. These offerings aim to support general health, overall well-being, nutrition, and...
Earth Science Tech Financial Statement Overview
Summary
Financial performance is a story of a successful turnaround, now showing solid profitability with a 51.7% gross margin and a pristine, debt-free balance sheet. However, the score is tempered by a recent -4.9% revenue decline, margin compression, and mixed cash flow quality, indicating growth is stalling and reported profits may be flattered by non-cash items.
Income Statement
72PositiveBalance Sheet
85Very PositiveCash Flow
55Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Jun 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.21M | 35.70M | 33.12M | 11.95M | 48.54K | 14.12K |
| Gross Profit | 17.67M | 25.49M | 24.30M | 7.83M | 22.06K | -8,516 |
| EBITDA | 4.83M | 3.39M | 3.54M | 1.47M | -382.19K | -219.21K |
| Net Income | 3.75M | 3.63M | 3.25M | 812.14K | -365.40K | 3.17M |
Balance Sheet | ||||||
| Total Assets | 10.86M | 8.97M | 7.07M | 3.88M | 2.73M | 76.94K |
| Cash, Cash Equivalents and Short-Term Investments | 2.66M | 2.16M | 2.12M | 697.72K | 35.76K | 26.94K |
| Total Debt | 444.28K | 96.21K | 401.24K | 246.59K | 974.11K | 780.69K |
| Total Liabilities | 2.78M | 1.93M | 3.22M | 1.63M | 1.61M | 1.88M |
| Stockholders Equity | 8.05M | 7.01M | 3.85M | 2.25M | 1.12M | -1.81M |
Cash Flow | ||||||
| Free Cash Flow | 1.61M | 1.18M | 3.62M | 1.18M | -1.01M | -166.39K |
| Operating Cash Flow | 1.47M | 1.94M | 4.37M | 1.21M | -1.01M | -168.11K |
| Investing Cash Flow | -1.08M | -1.90M | -1.88M | -26.52K | 0 | 1,712 |
| Financing Cash Flow | -746.95K | -712.92K | -1.72M | -517.88K | 1.02M | 173.18K |
Earth Science Tech Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and below the 200-day MA of 0.12, indicating a bearish trend. The MACD of 0.00 indicates Positive momentum. The RSI at 46.72 is Neutral, neither overbought nor oversold. The STOCH value of 43.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.
Earth Science Tech Risk Analysis
Earth Science Tech disclosed 38 risk factors in its most recent earnings report. Earth Science Tech reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksEarth Science Tech Peers Comparison
Overall Rating
- ETST67Neutral
CPIX59Neutral
SCYX53Neutral
RMTI52Neutral
TLPH45Neutral
COSM39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ETST | 67Neutral | $27.15M | 7.20 | 53.35% | ― | 1.09% | 35.79% |
| CPIX | 59Neutral | $91.70M | 1.44 | 202.58% | 20.91% | -39.11% | -241.27% |
| SCYX | 53Neutral | $33.99M | -2.82 | -18.65% | ― | 543.96% | 72.49% |
| RMTI | 52Neutral | $28.54M | -5.01 | -14.03% | ― | -3.96% | 7.97% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TLPH | 45Neutral | $54.50M | -3.34 | -87.28% | ― | -96.30% | 35.57% |
| COSM | 39Underperform | $23.76M | -0.31 | -118.89% | ― | 33.82% | 34.05% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ETST | Earth Science Tech | 0.09 | -0.05 | -32.86% | |
| TLPH | Talphera, Inc. | 1.03 | -0.22 | -17.20% | |
| RMTI | Rockwell Medical | 7.38 | -1.81 | -19.70% | |
| SCYX | SCYNEXIS Inc | 3.33 | -1.36 | -28.94% | |
| CPIX | Cumberland Pharmaceuticals Inc. | 6.63 | 4.99 | 305.26% | |
| COSM | Cosmos Holdings | 0.21 | -0.52 | -71.33% |
Earth Science Tech Corporate Events
Earth Science Tech CFO Resigns; CEO Assumes Interim Role
NeutralOn October 25, 2026, Earth Science Tech, Inc. announced that Ernesto L. Flores resigned as Chief Financial Officer and as a member of the Board of Directors, including his role on the Compensation Committee, with the company stating his departure did...
Earth Science Tech Shareholders Back Governance and Uplisting Plan
PositiveEarth Science Tech, Inc. held its first annual meeting of stockholders virtually on August 31, 2026, where shareholders re-elected all seven directors and ratified Semple, Marchal & Cooper, LLP as the independent registered public accounting firm for...
Earth Science Tech Acquires Zoolzy to Expand Healthcare Operations
PositiveOn August 19, 2026, Earth Science Tech, Inc. announced it had acquired Zoolzy LLC, a Doral, Florida-based wholesale distributor of active pharmaceutical ingredients and finished FDA-approved prescription products operating from a 3,684-square-foot fa...
Earth Science Tech Expands Footprint With Meduvo Acquisition
PositiveOn August 11, 2026, Earth Science Tech, Inc. entered into an agreement to acquire Meduvo LLC, a compounding pharmacy based in La Verne, California, in a transaction deemed immaterial in size. The deal was structured as a related-party transaction wit...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 10, 2026